AEQUASYAL® (CS18)

Evaluation of the activity, tolerance, and acceptability of AEQUASYAL® in the relief of signs and symptoms of xerostomia. A multicenter, randomized, single-blind investigator-controlled comparative study conducted on patients suffering from xerostomia (2005).

Treatment of dry mouth symptoms (iatrogenic hyposialia or asialia of medicinal or radiotherapy origin). OGT-based solution for endo-buccal sprays. Controlled clinical trials demonstrate that the solution rapidly and significantly improves the symptoms associated with dry mouth.

Triple effect of the solution:

  • lubricant
  • adhesive, with the formation of a lipid film whose role is to limit insensible water loss and restore the viscoelasticity of the oral mucosa
  • Protective against local aggressions

PUBLICATIONS

ARTICLE 1

‘’Efficacy of a new oral lubricant solution in the management of Psychotropic drug-induced Xerostomia’’

Authors

Stéphane Mouly, MD, PhD, Jean-Baptiste Orler, MD, Yves Tillet PharmD, Anne-Claude Coudert, PharmD, Frantz Oberli, PhD, Philip Preshaw, MD, Jean-François Bergmann, MD

Journal

Journal of Clinical Psychopharmacology: Volume 27. No. 5. October 2007

ARTICLE 2

‘’Xerostomia in the elderly: value of a local treatment by application of an oxidized glycerol triester oral spray compared to a reference artificial saliva’’

Author

Michel Salom

Journal

La Revue de Gériatrie, Tome 31 No. 10 – Dec. 2006 _

ARTICLE 3

‘’Management of xerostomia in older patients: A randomised controlled trial Evaluating the efficacy of a new oral lubricant solution’’

Authors

Stéphane Mouly, Michel Salom, Yves Tillet, Anne-Claude Coudert, Frantz Oberli, Philip M. Preshaw, Stéphane Desjonquères, Jean-François Bergmann

Journal

Drugs & Aging 2007; 24(11); 957-965

AEQUASYAL-product – compress

Aequasyal Instructions

Presentation

Aluminum bottle with a 0.1 ml metering pump containing 40 ml of solution, i.e., 400 doses.

Regulation

Class I medical device according to the regulatory requirements of Directive 93/42/EEC and Amendments.
Manufacturer: Laboratoires Carilène
Tour Franklin, 100-101 Terrasse Boieldieu
92800 Puteaux

Partner

Medical Devices

Developed by Carilène Laboratories and validated by clinical studies

Aequasyal

DRY MOUTH

Relief of the signs and symptoms of xerostomia through a protective lipid film on mucous membranes

CURRENTLY UNDER SUBMISSION ACCORDING TO MDR REQUIREMENTS
Herpecare

GENITAL HERPES

Covering and protective gel acting on the functional signs of genital herpes.

CURRENTLY UNDER SUBMISSION ACCORDING TO MDR REQUIREMENTS
Acura

LABIAL HERPES

Covering and protective gel acting on the functional signs of labial herpes.

CURRENTLY UNDER SUBMISSION ACCORDING TO MDR REQUIREMENTS